Oscillations of cardiac wave length and proarrhythmia

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 382, Issue 4, 2010, Pages 367-376

  Hondeghem, L M ^a   Dumotier, B ^b   Traebert, M ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Disturbances of conduction; Disturbances of repolarization; Proarrhythmia; QT prolongation; Torsade de pointes

Indexed keywords

DOFETILIDE; SEA ANEMONE TOXIN; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART CONDUCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE POTENTIAL; HEART PROARRHYTHMIA; HEART REPOLARIZATION; ISOLATED HEART; NONHUMAN; OSCILLATION; PATHOGENESIS; RABBIT; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CELL CULTURE TECHNIQUES; CELL LINE; FEMALE; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; PATCH-CLAMP TECHNIQUES; RABBITS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TORSADES DE POINTES;

EID: 77957553810     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0549-y     Document Type: Article

References (24)

1. F Dessertenne 1966 La tachycardia ventriculaire à deux foyers opposés variables Arch Mal Coeur 59 263 272 1:STN:280: DyaF287htFGjtQ%3D%3D 4956181
2. E Ficker W Jarolimek J Kiehn A Baumann AM Brown 1998 Molecular determinants of dofetilide block of HERG K+ channels Circ Res 82 386 395 1:CAS:528:DyaK1cXhtlaqu7Y%3D 9486667
3. LM Hondeghem 1994 Computer aided development of antiarrhythmic agents with class IIIa properties J Cardiovasc Electrophysiol 5 711 721 1:STN:280:DyaK2M7gt12gsQ%3D%3D 10.1111/j.1540-8167.1994.tb01193.x 7528608
4. LM Hondeghem 2006 Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs J Cardiovasc Electrophysiol 17 337 340 10.1111/j.1540-8167.2006.00347.x 16643415 (Pubitemid 43344952)
5. LM Hondeghem 2008 QT prolongation is an unreliable predictor of ventricular arrhythmia Heart Rhythm 5 1210 1212 10.1016/j.hrthm.2008.05.006 18675236
6. LM Hondeghem BG Katzung 1977 Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels Biochim Biophys Acta 472 373 398 1:CAS:528:DyaE1cXjtFOisQ%3D%3D 334262
7. LM Hondeghem DJ Snyders 1990 Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use-dependence Circulation 81 686 690 1:STN:280:DyaK3c7isV2ktg%3D%3D 2153477
8. L Hondeghem L Carlsson G Duker 2001 Instability and triangulation of the action potential predict serious proarrhythmia, but APD prolongation is antiarrhythmic Circulation 103 2004 2013 1:STN:280:DC%2BD3M3kvFWmtQ%3D%3D 11306531
9. LM Hondeghem HR Lu D van RossemK F Clerck 2003 Detection of proarrhythmia in the female rabbit heart: blinded validation J Cardiovasc Electrophysiol 14 287 294 10.1046/j.1540-8167.2003.02466.x 12716112
10. G Isenberg U Ravens 1984 The effects of the Anemonia sulcata toxin (ATX II) on membrane currents of isolated mammalian myocytes. The effects of the Anemonia sulcata toxin (ATX II) on membrane currents of isolated mammalian myocytes J Physiol 357 127 149 1:CAS:528:DyaL2MXhvFamtg%3D%3D 6150992
11. CT January V Chau JC Makielski 1991 Triggered activity in the heart: cellular mechanisms of early after-depolarizations Eur Heart J 12 Suppl F 4 9 1725155
12. PJ Kannankeril DM Roden 2007 Drug-induced long QT and torsade de pointes: recent advances Curr Opin Cardiol 22 39 43 10.1097/HCO.0b013e32801129eb 17143043 (Pubitemid 44901054)
13. T Lewis AN Drury 1926 Revised views of refractory period in relation to drugs reputed to pro-long it and in relation to circus movement Heart 13 95 100
14. RJ Lipicky 1993 A viewpoint on drugs that prolong the QTc interval Am J Cardiol 72 53B 54B 1:STN:280:DyaK2c%2FnvV2gtw%3D%3D 10.1016/0002-9149(93)90042-B 8256757
15. HR Lu P Remeysen K Somers A Saels F De Clerck 2001 Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model J Cardiovasc Electrophysiol 12 538 545 1:STN:280: DC%2BD3MzhtlWhug%3D%3D 10.1046/j.1540-8167.2001.00538.x 11386514
16. P Milberg L Eckardt HJ Bruns J Biertz S Ramtin N Reinsch D Fleischer P Kirchhof L Fabritz G Breithardt W Haverkamp 2002 Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes J Pharmacol Exp Ther 303 218 225 1:CAS:528:DC%2BD38XnsV2qsLs%3D 10.1124/jpet.102.037911 12235254
17. J Morganroth 1987 Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias Am J Cardiol 60 1276 1281 1:STN:280:DyaL1c%2Fntl2qtA%3D%3D 10.1016/0002-9149(87)90608-4 3318368
18. S Nattel 1999 The molecular and ionic specificity of antiarrhythmic drug actions J Cardiovasc Electrophysiol 10 272 282 1:STN:280:DyaK1M7ovVKhsg%3D%3D 10.1111/j.1540-8167.1999.tb00673.x 10090234
19. YW Qian YW Qian RJ Sung SF Lin R Province WT Clusin 2003 Spatial heterogeneity of action potential alternans during global ischemia in the rabbit heart Am J Physiol Heart Circ Physiol 285 H2722 H2733 1:CAS:528:DC%2BD2cXhsVCh 12907420
20. DM Roden 1993 Current status of class III antiarrhythmic drug therapy Am J Cardiol 72 50B 52B 10.1016/0002-9149(93)90041-A
21. DM Roden 2005 Drug-induced prolongation of QT interval N Engl J Med 350 1013 1022
22. RR Shah LM Hondeghem 2005 Refining detection of drug-induced proarrhythmia: QT interval and TRIaD Heart Rhythm 2 758 772 10.1016/j.hrthm. 2005.03.023 15992736 (Pubitemid 40903686)
23. Vaughan Williams EM (1989) Classification of antiarrhythmic agents. In: Vaughan Williams EM (ed) Antiarrhythmic drugs. Handbook of experimental pharmacology series (No 89), chapter 2. Springer, Berlin, pp 45-67
24. M Viitasalo KJ Paavonen H Swan K Kontula L Toivonen 2005 Effects of epinephrine on right ventricular monophasic action potentials in the LQT1 versus LQT2 form of long QT syndrome: preferential enhancement of " triangulation" in LQT1 Pacing Clin Electrophysiol 28 219 227 10.1111/j.1540-8159.2005.09404.x 15733182 (Pubitemid 40393110)